Conditioning of beta(1)-adrenoceptor effect via beta(2)-subtype on L-type Ca(2+) current in canine ventricular myocytes

Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1329-37. doi: 10.1152/ajpheart.2000.279.3.H1329.

Abstract

We investigated the roles of beta(1)- and beta(2)-receptors (beta-AR) in adrenergic enhancement of L-type Ca(2+) current (I(CaL)) in canine ventricular myocytes. Isoproterenol and l-norepinephrine produced a monophasic and a biphasic concentration-I(CaL) relationship (CR), respectively. alpha(1)-AR inhibition with prazosin and beta(2)-AR stimulation with zinterol or l-epinephrine shifted the CR of l-norepinephrine leftward. Zinterol (50 nM) and l-epinephrine (10 nM), but not prazosin, altered the biphasic CR of l-norepinephrine to a monophasic CR. Zinterol and l-epinephrine applied after l-norepinephrine had no effect on I(CaL). beta(2)-AR inhibition with ICI-118551 reduced the E(max) of isoproterenol and l-norepinephrine by 60% and abolished the augmentation of l-norepinephrine by zinterol and l-epinephrine. Carbachol (100 nM) modestly reduced the I(CaL) response to beta(1)-AR stimulation but abolished the enhancement via beta(2)-AR. Zinterol augmented the enhancement of I(CaL) by forskolin, IBMX, and theophylline, but not in the presence of CGP-20712A. We conclude that selective beta(2)-AR stimulation does not increase I(CaL) but enhances adenylyl cyclase activity when stimulated via beta(1)-AR and with forskolin. beta(2)-AR activity preconditions adenylyl cyclase for beta(1)-AR stimulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adrenergic Agonists / pharmacology
  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic beta-1 Receptor Agonists
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Calcium Channels, L-Type / metabolism*
  • Cells, Cultured
  • Cholinergic Agonists / pharmacology
  • Colforsin / pharmacology
  • Dogs
  • Dose-Response Relationship, Drug
  • Epinephrine / pharmacology
  • Heart Ventricles / cytology
  • Heart Ventricles / metabolism*
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Norepinephrine / pharmacology
  • Patch-Clamp Techniques
  • Phosphodiesterase Inhibitors / pharmacology
  • Receptors, Adrenergic, beta-1 / metabolism*
  • Receptors, Adrenergic, beta-2 / metabolism*

Substances

  • Adrenergic Agonists
  • Adrenergic alpha-Antagonists
  • Adrenergic beta-1 Receptor Agonists
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Antagonists
  • Calcium Channels, L-Type
  • Cholinergic Agonists
  • Phosphodiesterase Inhibitors
  • Receptors, Adrenergic, beta-1
  • Receptors, Adrenergic, beta-2
  • Colforsin
  • Norepinephrine
  • Epinephrine